Nasdaq · Biotech stocks database
ACB — Aurora Cannabis Inc. ☆
ACB (Aurora Cannabis Inc.) stock: $5.24, $324.7M market cap, $96.0M cash, $258.7M EV, $341.8M fully diluted market cap. Data from Fully Diluted's biotech stocks database.
Overview
Catalysts
Assets
Pipeline
Trials
Holders
News
What they do
Aurora Cannabis is a global cannabis company headquartered in Alberta, Canada, operating in medical and consumer cannabis markets, with production and distribution across Canada, Europe, Australia, and New Zealand.
Source: company website via company website
Balance sheet
Cash $96.0M Debt $30.0M Net cash $66.0M Enterprise value $258.7M Basic shares 62.0M shares Fully diluted shares 65.2M shares Fully diluted market cap $341.8M Cash per share $1.55
Cash figures as of 2025-03-31. Database snapshot: 2026-11-07.
Share structure
Cap table components pending verification.
Price history Loading ACB daily closes…
Loading price history…
Asset data not yet available for this company.
No lead program on file for this company.
No active ClinicalTrials.gov trials matched to this company as sponsor or collaborator.
Specialist fund holders Tracked specialist funds: ADAR1 Capital Management, Aisling Capital, Ally Bridge Group, Avoro Capital Advisors, BVF Partners, Baker Bros. Advisors, Boxer Capital, Braidwell LP, Casdin Capital, Cormorant Asset Management, DAFNA Capital, Deerfield Management, EcoR1 Capital, Frazier Life Sciences, Great Point Partners, Ikarian Capital, Logos Global Management, OrbiMed Advisors, Perceptive Advisors, RA Capital Management, RTW Investments, Sphera Biotech, Stonepine Capital, Tang Capital Partners, Vivo Capital.
None of the tracked specialist funds reported a position in the latest 13F snapshot.
Fully Diluted · Free biotech stocks database. Figures are sourced from SEC filings and company disclosures; not investment advice.